CF Industries (CF) › Analysis

CF Industries (CF) stock analysis, November 3, 2026: Pullback in an uptrend, evidence evenly balanced before earnings

Published November 3, 2026 · CF chart, levels and live analysis

CF Industries (CF) fell about 2.1% to $117.85 on November 3, 2026, the day before earnings, while the S&P 500 edged higher. No news explains the drop. The stock is pulling back inside a weekly uptrend and sits just above its 200-day average at $116.68. The balance of evidence is even, and conviction is low because nothing in the price action yet confirms a direction.

Why it matters

There is no company event behind today's move. Our news search found nothing from CF itself, so the 2.1% decline, against a 0.2% gain in the S&P 500 (SPY), is not explained by headlines. Volume is running about 44% below its 20-day average, which says the selling lacks urgency. The stock is also drifting into earnings tomorrow, and that is a more likely reason for the caution than any single piece of news.

The more useful context is what was already in the price. On October 28, 2026, UBS ranked the fertilizer group and favored nitrogen into 2027, Investing.com reported. The bank cited returning demand, Middle East supply disruptions and elevated European gas costs. CF's closing peak of $123.30 came two days later, on October 30, and the stock has given back 4.4% since. The good news was received, then sold into.

On the five-day numbers, the market did nearly all of the work. CF is down 2.2% over five days and SPY is down 2.1%, so the stock has moved almost exactly with the index. No sector ETF figure is available to split out a sector effect. Over one month the picture is better: CF is up 2.5% while SPY is down 2.1%. Over 50 days it trails SPY by 2.6 points, and over 200 days by 2.4.

The argument about CF is over how long nitrogen prices stay high. UBS raised its 2027 and 2028 estimates for CF by 24% and 16% and sees fair value in the mid-$130s. The backdrop supports that view. The Trump administration is paying out about $8 billion to farmers strained by high fuel and fertilizer costs from the war in Iran, The Wall Street Journal reported on October 21, 2026. The same price levels that lift CF's margins are squeezing its customers, and the relief keeps those customers able to buy. The counterargument follows from that. Elevated prices rest on supply disruptions and gas costs that can ease, and UBS's own article is rated neutral in tone, not a call that the stock will rerate.

Valuation sits between the two views. Twenty analysts rate CF a hold, with a mean price target of $128.69, which is 8.4% above the current price. Targets range from $105 to $195.72. That spread is wide, and it shows that no one is sure what nitrogen earnings look like in 2027. The stock is up 52.4% this year but down 3.9% over six months, and it sits 15.4% below its 52-week high of $139.27.

What the evidence says

The long-term trend is intact. CF trades above its 40-week average, and the year-to-date gain of 52.4% reflects a large advance. The stock is now in a consolidation phase. It is below its 10-week average and below its 50-day average of $123.03, and the six-month return is slightly negative. That is a pause inside an uptrend, not a broken thesis, though the stock is lagging the market while it pauses.

For the next two to six weeks the evidence is even, and conviction is low, with none of four confirming points in place. The pullback is real but not stretched: RSI is 46.6, neither oversold nor strong. The stock is lagging the S&P 500 against the direction of the weekly trend, so the short-term evidence and the long-term trend point different ways. That is why trend alignment scores none.

The strongest case against an even reading is a positive one. The weekly trend is up, the 200-day average is holding so far, UBS has raised estimates sharply, and the mean target is above the price. It does not tip the balance because the price has not responded. CF is below both its 10-week and 50-day averages, it is underperforming the index, and today's drop came on a day the market rose. Until buyers show up in price and volume, the fundamental case stays unconfirmed, and that is why conviction is not higher.

Levels that matter

The structure holds above $116.68, the 200-day average, and the stock is sitting just above it. A break below that level is the first crack. The trend ends below $113.68, a swing zone, and a weekly close under it would end the uptrend. Below that, the next supports are $110.30 and the round $100.

The breakout level is a daily close above $123.03, the 50-day average, on volume above its 20-day average. That would be the first sign that buyers are back, with $125 as the next round-number resistance. From $123.03 the first target is $130.24, a swing zone, at 1.0 to 1 against a stop at $115.71, which is the 200-day average minus a quarter of the 14-day ATR. The second target is the 52-week high of $139.27, at 2.2 to 1. The math does not reach the 3 to 1 that makes a breakout worth the risk. It would take a cheaper entry nearer the 200-day average or a target beyond the 52-week high to change that.

What would change the picture

A weekly close below $113.68 would end the weekly uptrend and turn the pullback into a larger decline. The non-price fact most likely to do it is evidence that the nitrogen outlook behind UBS's higher estimates is not holding, for example a fading of the Middle East supply disruption or earnings guidance that points to softer nitrogen pricing in 2027. Without a price break, the uptrend stays in place.

What to watch

Get a message when the CF picture changes — the agent team watches the levels and the news for you.Create a free account

More CF analyses

Research & education, not advice. MarketCrew is AI-powered and can make mistakes.